OptiNose, Inc.
OPTN · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.28 | -0.60 | 0.09 |
| FCF Yield | -10.80% | 2.41% | -7.58% | -10.16% |
| EV / EBITDA | -21.25 | 26.83 | 27.68 | -74.33 |
| Quality | ||||
| ROIC | -11.32% | 0.38% | -2.15% | -6.55% |
| Gross Margin | 90.55% | 91.28% | 89.90% | 90.33% |
| Cash Conversion Ratio | 0.52 | -5.20 | -22.48 | 2.07 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.72% | 0.85% | -0.97% | -1.97% |
| Free Cash Flow Growth | -717.09% | 121.14% | 43.69% | 28.68% |
| Safety | ||||
| Net Debt / EBITDA | -7.15 | 9.77 | 7.64 | -13.64 |
| Interest Coverage | -1.55 | 0.07 | -0.39 | -1.32 |
| Efficiency | ||||
| Inventory Turnover | 0.15 | 0.17 | 0.18 | 0.17 |
| Cash Conversion Cycle | 620.64 | 613.20 | 459.03 | 530.95 |